Our data indicate a link between obesity and hypothalamic neurodegeneration in SPG11 and imply that specific metabolic interventions may prevent obesity despite severely impaired mobility in SPG11. Here, SPG11 is linked to obesity due to melanocortin 4 receptor deficiency.